Wilmington, Delaware, Tebchaws Asmeskas, Lub Yim Hli 29, 2023 (GLOBE NEWSWIRE) - Kev Tshawb Fawb Kev Lag Luam Kev Lag Luam Inc. - Lub khw muag tshuaj thoob ntiaj teb tau npaj siab yuav vam meej ntawm CAGR ntawm 6% txij xyoo 2023 txog 2031. Raws li daim ntawv tshaj tawm luam tawm los ntawm TMR ,tus nqi ntawm US $ 53.4 billiontau cia siab tias yuav muaj kev lag luam hauv 2031. Raws li xyoo 2023, kev lag luam rau cov tshuaj intermediates yuav tsum kaw ntawm US $ 32.8 billion.
Nrog rau kev nce thoob ntiaj teb cov pej xeem thiab hnub nyoog, muaj kev xav tau ntau ntxiv rau ntau yam tshuaj, tsav qhov kev thov rau cov khoom nruab nrab siv hauv lawv cov khoom.Kev loj hlob hauv kev lag luam kws tshuaj ncaj qha cuam tshuam rau kev lag luam xav tau.
Thov rau Sample PDF Copy ntawm:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54963
Kev sib tw toj roob hauv pes
Cov neeg tseem ceeb hauv lub ntiaj teb kev lag luam tshuaj intermediates tau ua tiav raws li cov ntsiab lus tseem ceeb xws li kev saib xyuas lub tuam txhab, cov khoom lag luam, kev saib xyuas nyiaj txiag, kev tsim kho tsis ntev los no, thiab cov tswv yim kev lag luam sib tw.Cov tuam txhab loj profiled nyob rau hauv lub ntiaj teb no kws tshuaj intermediates lag luam qhia yog
- BASF SE
- Lonza Group
- Evonik Industries AG UA
- Cambrex Corporation
- DSM
- Aceto
- Albemarle Corporation
- Vertellus
- Chemcon Specialty Chemical Ltd.
- Chiracon GmbH
- R. Lub Neej Sciences Private Limited
Kev Txhim Kho Tseem Ceeb hauv Pharmaceutical Intermediates Market
- Thaum Lub Xya Hli 2023 - Evonik thiab Heraeus Precious Metals tau koom tes los nthuav ob lub tuam txhab kev pabcuam rau cov khoom siv tshuaj muaj zog heev (HPAPIs).Kev sib koom tes siv zog ua kom muaj peev xwm HPAPI tshwj xeeb ntawm ob lub tuam txhab thiab muab cov neeg siv khoom sib koom ua ke los ntawm theem ua ntej kev kho mob mus rau kev tsim khoom lag luam.
-
- Albemarle tau nqis peev hauv kev tshawb fawb thiab kev tsim kho los tsim cov thev naus laus zis tshiab los tsim cov tshuaj intermediates.Lub tuam txhab aims muab cov kev daws teeb meem tshiab rau nws cov neeg siv khoom.
- Cambrex nthuav dav nws lub peev xwm tsim khoom rau cov neeg nruab nrab siab thiab APIs ntawm nws qhov chaw hauv Charles City, Iowa.Qhov kev nthuav dav no txhawm rau ua kom tau raws li qhov xav tau loj zuj zus rau cov khoom siv tshuaj zoo tshaj plaws
- Merck tau nqis peev hauv cov thev naus laus zis tshiab rau kev tsim tshuaj.Lub tuam txhab tau ua haujlwm los txhim kho nws cov peev txheej hauv kev tsim cov khoom lag luam siab ntshiab rau ntau yam kev siv tshuaj.
- Novartis International tau ua haujlwm los txhim kho nws cov txheej txheem tsim tshuaj lom neeg los tsim cov khoom nruab nrab zoo rau nws cov khoom siv tshuaj.Lub tuam txhab tsom xam suav nrog optimizing efficiency thiab sustainability.
Kev tsom mus rau kev txhim kho tshuaj tshiab thiab kev xav tau ntau yam ntawm APIs pab txhawb rau qhov kev thov rau cov neeg nruab nrab.Cov tshuaj intermediates feem ntau yog tsim los ntawm cov khoom siv qib siab, uas yog siv rau hauv kev lag luam tshuaj thiab tshuaj pleev ib ce.Qhov kev thov nce siab hauv cov kev lag luam no yog nthuav dav thoob ntiaj teb kev lag luam tshuaj intermediates.
Kev siv nyiaj ntau ntxiv hauv kev tshawb fawb thiab kev tsim kho thiab kev nce qib hauv cov kev kho tshiab tau xav tias yuav txhim kho qhov kev loj hlob ntawm kev lag luam tshuaj intermediates.
Cov ntsiab lus tseem ceeb ntawm Kev Tshawb Fawb Kev Ua Lag Luam
- Raws li xyoo 2022, kev lag luam tshuaj intermediates tau muaj nuj nqis ntawm US $ 31 billion
- Los ntawm cov khoom lag luam, cov tshuaj feem ntau nruab nrab ntu nyiam qhov kev thov siab, sib sau cov nyiaj tau los siab thaum lub sijhawm kwv yees.
- Raws li daim ntawv thov, ntu kab mob sib kis tau cia siab tias yuav ua tus thawj tswj hwm kev lag luam thaum lub sijhawm kwv yees
- Raws li cov neeg siv kawg, ntu kws tshuaj & thiab biotechnology feem ntau yuav yog tus thawj coj thoob ntiaj teb kev lag luam tshuaj intermediates thaum lub sijhawm kwv yees.
Pharmaceutical Intermediates Kev Ua Lag Luam: Qhov Tseem Ceeb Trends thiab Opportunistic Frontiers
- Vim tias kev ua raws li cov txheej txheem kev ua lag luam, thiab cov kev coj ua zoo (GMP) hauv kev lag luam tshuaj, lub khw muag tshuaj thoob ntiaj teb yuav tsum loj hlob nyob rau yav tom ntej.
- Pharmaceutical intermediates yog siv nyob rau hauv zus tau tej cov tshuaj generic Yog li qhov kev thov nce rau cov tshuaj generic vim lawv cov nqi-zoo yog tsav lub lag luam loj hlob.
- Kev loj hlob sai ntawm kev lag luam biopharmaceutical thiab loj hlob peev hauv kev tshawb fawb thiab kev tsim kho kev ua ub no kom pom cov tshuaj tshiab thiab txhim kho cov txheej txheem tsim khoom tau ua rau kev txhim kho cov tshuaj tshiab tshiab, txhawb kev lag luam kev loj hlob.
Post lub sij hawm: Sep-20-2023